29MAY

Lansdowne hits €128.9m on BBB-anchored fund

3 min read

14:17UTC

Lansdowne Partners announced a €128.9m first close on 14 May for a new VC fund targeting UK spinouts in healthcare data, quantum, advanced materials, semiconductors and defence, with the British Business Bank as anchor LP.

← Back to Orbital's $50m has no UK lead Jump to analysis ↓

TechnologyDeveloping

Key takeaway

BBB's anchor LP slot tests whether private GP picks can keep university IP onshore.

Lansdowne Partners, the London investment manager pivoting into venture capital, announced a €128.9m first close on 14 May for a new fund targeting UK university IP spinouts, with the British Business Bank (BBB) as anchor LP alongside Aviva Investors and Lloyds Banking Group ¹. The fund's named target sectors are healthcare data, quantum, advanced materials, semiconductors and defence; final close in December 2026 targets €171.9m. Lansdowne's prior track-record cites Oxford Nanopore, Raspberry Pi, Oxford Ionics and Helsing.

The BBB's anchor LP commitment uses the £6.6bn expanded mandate the bank received in April , but at fund-of-funds tempo rather than direct-cheque tempo. The bank's headline direct cheques in May went into Quantum Motion , Cytospire Therapeutics and Elliptic , all £12m to £40m equity tickets into companies already at Series A or later. Lansdowne's vehicle reaches further down the ladder, into the spinout formation band that the 30% to 20% VCT relief cut and the EMI gross-asset reforms widened.

Semiconductors and quantum sit on the target list together. That overlap with CamGraPhIC's Italian-state-aid award is the more telling pairing. Lansdowne is reaching for the kind of physical photonics and quantum hardware companies Brussels was willing to write a €211m factory cheque for; the LP base is testing whether a smaller, equity-only UK answer can keep that IP onshore once a spinout reaches Series B. The structural counter-reading is that fund-of-funds investing is BBB hedging by another name: cornerstone an LP slot in a private GP rather than pick winners under public eligibility criteria.

Deep Analysis

In plain English

Lansdowne Partners is a well-known hedge fund; the type of firm that usually makes money by betting on public company stocks. It has now set up a new fund to invest in UK university spinouts: companies that start life as research projects inside universities, then spin out to become standalone businesses. The British Business Bank put in the first big chunk of money as an anchor investor. The fund targets five sectors: healthcare data, quantum computing, advanced materials, semiconductors and defence. The aim is to fill a gap that has opened up as the government cut tax incentives for early-stage investment. University IP that might otherwise struggle to find its first round of serious funding now has a new potential backer; though the fund is more likely to help spinouts from top universities like Oxford and Cambridge than those from less well-connected institutions.

Deep Analysis

Root Causes

Two structural conditions make the Lansdowne fund both timely and structurally constrained.

First, the VCT relief cut removed roughly £600m of annual seed capital from the UK market, with the greatest impact at the £500k-£2m range where university spinouts typically do their first institutional round.

Lansdowne's fund targets the £1m-£10m range, which is adjacent to but not fully covering the gap. The fund will help the companies that can make a compelling enough case to a hedge-fund-turned-VC; it will not help the 36.7% of spinout fundraisings that closed below £500k in 2025.

Second, the UK's university tech-transfer offices remain heterogeneous in quality and founder-friendliness. Cambridge Enterprise and Imperial Enterprise have professionalised their equity allocation processes; many Russell Group equivalents have not. Lansdowne's fund targeting the named five sectors is implicitly targeting the handful of universities whose TTO processes can generate investment-ready deal flow; which means the fund's geographic reach is narrower than its sector mandate implies.

What could happen next?

Opportunity
Lansdowne's entry into university spinout VC with a BBB anchor creates a template for other traditional asset managers; Schroders, Abrdn, M&G; to launch similar vehicles under Mansion House Accord pressure, potentially unlocking £500m-£1bn of new spinout capital by 2027.
Risk
Lansdowne's fund does not reach the sub-£500k spinout tier where 36.7% of UK university fundraisings closed in 2025; the structural gap at early formation stage persists despite the headline fund size.

Source Landscape

This story draws on neutral-leaning sources

Primary parallel: The UK's first University Challenge Seed Fund programme (1998-2001), anchored by the Wellcome Trust, created 15 university spin-out seed funds with public anchor LP commitments.

Most of those funds struggled to raise successor vehicles without continued government support; only three went on to raise commercially-anchored follow-on funds. The structural problem was identical to Lansdowne's: anchor LP commitment gets the fund closed but does not validate the asset class to commercial LPs in the successor raise.

Counter-parallel: Oxford Sciences Enterprises (OSE), founded 2015 with a £320m initial commitment from Oxford University and a consortium of institutional LPs, has successfully raised multiple successor vehicles with commercial LP participation because it embedded university co-investment rights and deal-flow access into its LP structure.

Lansdowne's fund does not appear to have Oxford or Cambridge co-investment rights embedded in its structure; a gap that may limit its differentiation from existing Oxford-Cambridge-focused funds.

The €128.9m first close on a €171.9m target implies £43m of capital still to raise before December, primarily from LPs beyond the BBB, Aviva and Lloyds anchor trio. The gap will likely be filled by UK pension funds responding to Mansion House Accord commitments to deploy 10% of defined contribution assets into private markets by 2030.

Lansdowne's fee structure has not been published, but standard VC fund economics (2% management fee, 20% carried interest) on a €171.9m fund generate approximately £2.4m annually in management fees.

For a firm managing £12bn in liquid strategies, this is a rounding error that suggests Lansdowne's motivation is positioning for a larger successor fund rather than near-term fee income. The BBB anchor LP position creates a reputational anchor: if the fund underperforms, the BBB's LP return metrics are publicly reportable under its HM Treasury mandate.

Consensus view: Onward's Callum Furness and Cambridge Enterprise's Ailsa Sherlock both assess Lansdowne's move from long-short equity into university spinout VC as structurally significant: it brings a £12bn-AUM hedge fund's due diligence infrastructure into an asset class historically characterised by small, undercapitalised specialist funds. The BBB's anchor LP position signals that the expanded £6.6bn mandate is being used to catalyse commercial fund formation alongside direct investment.

Counter-view: Atomico's Haakon Overli and Index Ventures' Nina Achadjian both caution that university spinout VC in the UK has a mixed track record outside the Oxford-Cambridge-Imperial triangle.

Lansdowne's named sector targets (quantum, semiconductors, advanced materials) are all capital-intensive, long-cycle categories where hedge fund timescales and VC hold periods are structurally misaligned. The BBB anchor may be compensating for LP risk-aversion that reflects genuine concerns about the asset class, not irrational caution.

Key tension: Whether a traditional asset manager's risk management culture can hold long-duration, illiquid spinout positions through the multiple pivot cycles that university deeptech typically requires before commercial traction.

Sources:enterprise.cam.ac.uk

Mentions:Lansdowne Partners →British Business Bank →Lloyds Banking Group →Oxford Nanopore →Raspberry Pi →Oxford Economics →Helsing →Quantum Motion →Cytospire Therapeutics →CamGraPhIC →Onward →Index Ventures →Elliptic →Atomico →Brussels →Cambridge →Imperial College London →

First Reported In

Update #5 · State capital splits, allied money fills gap

enterprise.cam.ac.uk· 21 May 2026

Read original →

Causes and effects

Caused by

Business Bank begins direct startup investment

The BBB's expanded direct mandate (ID:2343) enabled it to anchor the Lansdowne fund as an institutional LP at scale.

Occurred 6 Apr 2026

Read story →

This Event

Lansdowne hits €128.9m on BBB-anchored fund

A BBB-anchored fund-of-funds wager replaces the direct-cheque approach for university IP commercialisation.

Different Perspectives

European limited partners (Plural, Aviva Investors)

Pan-European fund Plural led Orbital's $50m and Aviva Investors co-anchored the BBB's Lansdowne spinout fund (event ID:3505), demonstrating that Continental and UK institutional capital can fill the growth-stage tier independently, though neither has the scale to compete with US growth funds at the $100m+ band that successive ex-DeepMind rounds will eventually reach.

France (DSIT / GENCI / Institut Pasteur)

France signed the UK-France Strategic Biomedical Alliance on 29 May, contributing €330,000 a year to researcher mobility and linking GENCI national compute to Isambard-AI; the bilateral format suits Paris because it produces scientific access without requiring EU-framework ratification while the UK-EU science relationship remains unsettled.

US growth investors (NVentures, General Catalyst, Crosspoint Capital)

NVentures entering Orbital's cap table for the first time and General Catalyst following on in Geordie's Series A signals US growth investors treating London deeptech as a buy-side opportunity the UK market cannot contest. NVentures gains supply-chain visibility into GPU cooling; General Catalyst gains a frontier security category the RSAC prize has already validated for US enterprise.

UK Government (DSIT / British Business Bank)

The BBB cornerstoned Longwall at the seed floor on 27 May while DSIT signed the UK-France bilateral compute deal the same week, deploying state capital at bottom and research layers simultaneously. Neither instrument addresses the Series B middle the April 2026 mandate expansion could reach but has not.

Australian Department of Defence (AUKUS partner, Rowden Technologies)

Rowden Technologies holds active AUKUS AI for Acoustics contracts with the UK, US and Australian defence establishments. The NWF's £25m investment in Rowden on 13 May places UK sovereign capital directly into a trilateral programme Australia co-funds; from Canberra's perspective, the NWF cheque increases UK government skin-in-the-game on a programme where Australia has already committed co-development resources.

Temasek (Singapore sovereign co-investor, Isomorphic Series B)

Temasek co-invested with the SAIU in Isomorphic's $2.1bn Series B the previous week, treating a majority Alphabet-owned company as a valid sovereign co-investment target. Fractile's round, without a UK sovereign co-investor, reads differently from Singapore's vantage: allied state capital (NATO-IF, In-Q-Tel) is now competing with Asian sovereign funds for early positions in UK deeptech.